TrialJournal of diabetes investigation2024

Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus.

Katsuhiko Hagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.